Insurance

Magazine articles on HMO's and other insurance companies.

Old Articles: <Older 611-620 Newer>

Managed Care November 2004 Tony Berberabe	Military Brings Order To Formulary System Congress told the Department of Defense to create a uniform formulary for all the services, and cover all FDA-approved drugs.
Managed Care November 2004 Frank Diamond	DM's Cost-Effectiveness Doubted in CBO Report Congress's financial review agency says that not enough evidence exists to prove that disease management saves money. Many beg to differ.
Managed Care November 2004 Martin Sipkoff	OTC Status for Low-Dose Lovastatin Would Have Widespread Implications The FDA stands poised to approve OTC low-dose statins, following a similar change in United Kingdom.
Managed Care November 2004 Martin Sipkoff	Death of Community Rating Has Been Greatly Exaggerated The idea that everyone in a given geographical area should pay the same for health coverage has come under assault in recent years.
Managed Care November 2004 Jack Ebeler	Congress Should Provide Incentives For Adoption of EMR Systems One important way that we can improve care for people with chronic diseases is to have medical records that are online and accessible when needed.
Managed Care November 2004	Blues' Weight-Loss Program May Be Blueprint for MC Industry With 55 percent of its members obese or overweight and accounting for about $83.1 million in excess costs a year, even some of Blue Cross's sharpest critics agree that Blue Cross's programs are worthy.
Managed Care November 2004	Headlines On Deadline... What goes around comes around. At least that's what critics of the pharmaceutical industry seem to be saying as they gloat over reports that Novartis wants its employees to use more generic and over-the-counter medications.
Managed Care November 2004 John Carroll	Medicare Formulary Model Seen by Many as Too Inclusive The issue is how extensive the list of covered medications should be for the new Medicare pharmaceutical benefit. The stakes are enormous.
Managed Care November 2004	Tiered Formularies Open the Potential for Lack of Access to Needed Drugs Tiered formularies that have additional incentives for preferred medications could create the potential for therapeutic compromises.
Managed Care November 2004 Thomas Morrow	Pharmacogenetic, Pharmacogenomic Testing Rapidly Gaining Acceptance New tests will allow better determination of which therapies will work on which patients, thus improving care and reducing outlays for failed therapies.
<Older 611-620 Newer> Return to current articles.